Summary of Proposed Changes to 21 CFR 610 is Detailed in New Management Brief from Microtest Labs

The new scope of reusable medical device cleaning validations, resulting from the U.S. FDA's proposed changes to 21 CFR 610, is discussed in a new management brief available for download from Microtest Laboratories.
 
 
Spread the Word
Listed Under

Tags:
21 Cfr
21 CFR 600
21 CFR 610
21 CFR 680
Cleaning Validations
Manufacturing
Medical Device Cleaning
Medical Device

Industrys:
Medical
Manufacturing
Health

Location:
Agawam - Massachusetts - US

Subject:
Reports

April 2, 2012 - PRLog -- The new scope of reusable medical device cleaning validations, resulting from the U.S. Food and Drug Administration’s (FDA) proposed changes to 21 CFR 610, is discussed in a new management brief from Microtest Laboratories — available for download at http://www.microtestlabs.com/21-cfr-610-paper.


The FDA’s proposed amendments to 21 CFR Parts 600, 610, and 680, published in the Federal Register on June 21, 2011, for review and comment, are focused on expanding the scope of the current sections to allow for greater flexibility in testing methodology.

“Through these changes, the FDA is embracing the emergence of new non-culture based technologies. If approved, they will provide the opportunity to utilize these methods as alternatives to culture-based sterility tests,” explains James E.T. Gebo, B.S., M.P.A., RM (NRCM), Technical Representative, Laboratory Services, Microtest Laboratories, in the brief, “Summary of Proposed Changes to 21 CFR 610: The New Scope of Cleaning Validations.”

“The most significant proposed revision is the elimination of the specified sterility test methods,” writes Gebo. “But while the proposed changes seem extreme at first glance, in the grand scheme they are beneficial for all interested parties.”

The brief discusses the potential benefits, including the opportunity for manufacturers and quality control laboratories to streamline their testing and adopt new emerging sterility test technologies — such as rapid testing methods employing PCR — that will further support the drive to achieve quicker product release.

Download the new free management brief, “Summary of Proposed Changes to 21 CFR 610: The New Scope of Cleaning Validations,” at http://www.microtestlabs.com/21-cfr-610-paper.

# # #

Microtest is a leader in testing services and contract manufacturing for the medical device, pharmaceutical, and biotechnology industries. Based in Agawam, Massachusetts, U.S.A., the company’s expertise and flexible processes enhance product safety and security, accelerate time to market, and minimize supply chain disruption. For more information, visit http://www.microtestlabs.com or call 1-413-786-1680 or toll-free 1-800-631-1680. Follow Microtest Labs on Twitter @MicrotestLabs at http://twitter.com/MicrotestLabs.
End
Source:
Email:***@tizinc.com Email Verified
Phone:(413) 786-1680
Zip:01001-3807
Tags:21 Cfr, 21 CFR 600, 21 CFR 610, 21 CFR 680, Cleaning Validations, Manufacturing, Medical Device Cleaning, Medical Device
Industry:Medical, Manufacturing, Health
Location:Agawam - Massachusetts - United States
Subject:Reports
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Microtest Laboratories PRs
Trending News
Top Daily News
Top Weekly News



Like PRLog?
9K2K1K
Click to Share